How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
This is an appropriate question with the presentation of RT CHARM at ASTRO a few weeks ago. We have been utilizing hypofractionated NON-reconstruction PMRT and regional nodal breast RT for years in my practice given our large geographic catchment area. As a general rule, I feel it's always best prac...
Yes, routinely offering hypofractionation with RT CHARM and FABREC supporting it.
Additional information on the safety of hypofractionated nodal radiotherapy recently emerged. The 2024 ESMO presentation 2310 of HypoG-01 solidifies the use of nodal hypofractionation as a safe method to treat the breast or chest wall and nodal basins. A broad range of stages, pT1-3 & pN0-3, HER2, r...
It’s becoming increasingly difficult to rationalize conventionally-fractionated radiotherapy for breast cancer.